Australian Brands-Aspen Pharmacare-Australian Drugs-Glaxosmithkline

GSK sells Australian drugs to Aspen for $270 mln

A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company results

JOHANNESBURG/LONDON (Reuters) - GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare for 172 million pounds. Andrew Witty, chief executive of Britain's biggest drugmaker, said last month during quarterly results that he was looking for further ways to simplify the GSK business, following previous divestments in consumer health. The old Australian brands being bought by Aspen include herpes treatment Valtrex, epilepsy drug Lamictal and the antibiotic Amoxil. ... read more..

source:http://yhoo.it/Ovc9K4

Food And Drug Administration-Health Professionals-Obesity Epidemic-Healthday News

2 New Weight-Loss Drugs Won't Reverse U.S. Obesity Crisis

THURSDAY, July 19 (Healthday News) -- The U.S. Food and Drug Administration's approval of two new weight-loss Drugs within the past month -- the first such medications in 13 years -- won't be a panacea for America's obesity epidemic, health professionals say. read more..

source:http://yhoo.it/MMaQ3N

Chronic Health Conditions-High Blood Pressure-Medicaid Recipients-Medicaid Patients

Many Medicaid Patients Skip Drugs That Could Prevent Heart Trouble

FRIDAY, July 20 (Healthday News) -- Many Medicaid recipients with chronic health conditions that can lead to Heart Disease -- diabetes, high blood pressure and high cholesterol -- do not take their prescribed medications, a new study has found. read more..

source:http://yhoo.it/OM3AIh

Food And Drug Administration-Pre-Approval-Drugs-FDA

FDA says focused on tracking drugs after approval

Woodcock, Director of the Center for Drug Evaluation and Research at FDA, speaks during the Reuters Health Summit in New York

ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process. The FDA was responding to critics who say the agency is toothless when it comes to tracking the safety of drugs already on the market, when industry funds that supported pre-approval reviews tend to dry up. "We think we've really balanced this," Dr. ... read more..

source:http://yhoo.it/I1pqXo

Neglected Tropical Diseases-Pharmaceutical Companies-Global Health-Drugs

Big Pharma donates drugs for neglected diseases

LONDON (Reuters) - The world's major pharmaceutical companies joined forces with governments and leading global health organizations on Monday to donate drugs and scientific know-how to help control or wipe out 10 neglected tropical diseases by 2020. Drugmakers have been criticized in the past for not doing enough to fight diseases of the poor as they concentrate instead on conditions more prevalent in rich nations, such as high cholesterol. ... read more..

source:http://yhoo.it/zoDV2J

Healthday News-Drug Shortage-Alternatives-Adhd Drugs

A shortage of ADHD drugs has parents seeking alternatives for their kids. Find o...

A shortage of ADHD drugs has parents seeking alternatives for their kids. Find out your options here...http://ow.ly/8lkd2ADHD Drug Shortage Pushes Parents to Seek Substitutes - Health News -...ow.lyBy Serena GordonHealthDay ReporterFRIDAY, Jan. 6 (Healthday News) — If the current shortage of some drugs used to treat... read more..

source:health.com